Ranbaxy Laboratories said it has reached a settlement with the US Food and Drug Administration while setting aside USD 500 million to address its potential liability from a separate US Justice Department investigation.
first published: Dec 21, 2011 09:31 am
A collection of the most-viewed Moneycontrol videos.
U.S.-Iran Conflict Will Have Huge Impact On Global Markets, Businesses, Supply Chain: Nalin Mehta
Rising Bharat Summit 2026 | “Satellite Can Go Where Others Can’t” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | “AI Creates More Opportunities” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | Piyush Goyal Answers the Big India–US Trade Deal Question
